Literature DB >> 2191924

Non-prostatic malignant disease mimicking prostatic cancer.

B Kromann-Andersen1, P Sommer, A Glenthøj.   

Abstract

Three patients with pelvic tumours (2 cases of pelvic sarcoma and 1 case of metastatic bronchial carcinoma) presented with symptoms and signs suggestive of prostatic carcinoma. Transrectal ultrasonic scanning with perineal biopsy facilitated the diagnosis. The prognosis of pelvic sarcoma was poor following radiotherapy.

Entities:  

Mesh：

Year:  1990        PMID： 2191924     DOI： 10.1007/bf02549830

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  8 in total

1.  Intraductal carcinoma of the prostate gland.

Authors:  R K Rhamy; R D Buchanan; M J Spalding
Journal:  J Urol       Date:  1973-03       Impact factor: 7.450

2.  Secondary tumors of the prostate.

Authors:  D E Johnson; R Chalbaud; A G Ayala
Journal:  J Urol       Date:  1974-10       Impact factor: 7.450

3.  Metastatic renal carcinoma to the prostate gland: presentation as prostatic hypertrophy.

Authors:  R W Cihak; R Haas; C T Koenen; H Chinchinian
Journal:  J Urol       Date:  1980-05       Impact factor: 7.450

4.  Squamous cell carcinoma of the prostate: report of 2 cases and review of the literature.

Authors:  L J Mott
Journal:  J Urol       Date:  1979-06       Impact factor: 7.450

5.  Sarcoma of the bladder and prostate.

Authors:  A S Narayana; S Loening; G W Weimar; D A Culp
Journal:  J Urol       Date:  1978-01       Impact factor: 7.450

6.  Malignant lymphomas involving the prostate. A study of 13 cases.

Authors:  D G Bostwick; R B Mann
Journal:  Cancer       Date:  1985-12-15       Impact factor: 6.860

7.  Non-Hodgkin lymphoma arising in lower urinary tract.

Authors:  J A Heaney; R A Delellis; R A Rudders
Journal:  Urology       Date:  1985-05       Impact factor: 2.649

8.  Sarcoma and carcinosarcoma of the bladder in adults.

Authors:  S E Sen; R S Malek; G M Farrow; M M Lieber
Journal:  J Urol       Date:  1985-01       Impact factor: 7.450
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.